ABSTRACT
Right-sided infective endocarditis (IE) accounts for 5% to 10% of all IE cases. Compared with left-sided IE, it is more often associated with intravenous drug abuse and intracardiac devices, whereas the latter has become more prevalent in recent decades. The authors report the first case of IE in a heterotopic caval valved stent used for treating torrential tricuspid regurgitation. (Level of Difficulty: Advanced.).
Subject(s)
Heart Valve Prosthesis Implantation , Heart Valve Prosthesis , Tricuspid Valve Insufficiency , Cardiac Catheterization , Heart Valve Prosthesis Implantation/adverse effects , Humans , Stents , Treatment Outcome , Tricuspid Valve/diagnostic imaging , Tricuspid Valve/surgery , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve Insufficiency/surgeryABSTRACT
Preprocedural planning and postprocedural evaluation after transcatheter treatment of severe tricuspid regurgitation remain challenging and require further research and standardization. We illustrate the use of multimodality imaging techniques in 3 patients undergoing implantation of a novel custom-made bicaval valved stent for symptomatic treatment of severe tricuspid regurgitation. (Level of Difficulty: Advanced.).
ABSTRACT
Surgery on the tricuspid valve is well established in specialized centers because tricuspid valve insufficiency is frequently encountered and is often functional in nature. With the increasing adoption of catheter-based treatments, there is a growing interest in and need for interventional treatments for tricuspid valve insufficiency. The Tricento heart valve is a gentle, less invasive, catheter-based treatment option for patients not suited for surgery who are receiving optimized medical treatment.